36735-26-9

Basic information

• Product Name: 3-aMino-2-phenylquinoline-4-carboxylic acid
• Synonyms: 3-aMino-2-phenylquinoline-4-carboxylic acid
• CAS NO: 36735-26-9
• Molecular Formula: C₁₆H₁₂N₂O₂
• Molecular Weight: 264.27868
• Mol File: 36735-26-9.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-aMino-2-phenylquinoline-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-aMino-2-phenylquinoline-4-carboxylic acid(36735-26-9)
• EPA Substance Registry System: 3-aMino-2-phenylquinoline-4-carboxylic acid(36735-26-9)

Safety Data

• Hazardous Substances Data: 36735-26-9(Hazardous Substances Data)

Upstream product

• 613-89-8 2-Aminoacetophenone 
• 70-11-1 α-bromoacetophenone 
• 91-56-5 indole-2,3-dione 
• 1032-67-3 N-benzoylmethylphthalimide 
• 117439-99-3 2-phenyl-3-phthalimido-quinoline-4-carboxylic acid 

Downstream Products

• 108619-00-7 3-amino-2-phenyl-quinolin-4-ol 
• 109367-35-3 5-phenyl-pyrimido[4,5-c]quinolin-1-ylamine 
• 109964-80-9 1-chloro-5-phenyl-pyrimido[4,5-c]quinoline 
• 108982-16-7 N-(4-chloro-2-phenyl-[3]quinolyl)-acetamide 
• 109566-43-0 1-methoxy-5-phenyl-pyrimido[4,5-c]quinoline 
• 102241-29-2 4-phenoxy-2-phenyl-[3]quinolylamine 
• 114946-98-4 1-phenoxy-5-phenyl-pyrimido[4,5-c]quinoline 
• 5855-52-7 2-phenylquinolin-4-amine 
• 29202-73-1 1,3-dioxo-4-phenyl-2H-pyrrolo<3,4-c>quinoline 
• 174636-16-9 (-)-(S)-N-(α-ethylbenzyl)-3-amino-2-phenylquinoline-4-carboxamide 
• 174636-18-1 (S)-N-(1-phenylpropyl)-3-bromo-2-phenylquinoline-4-carboxamide 

Relevant articles and documents

NOVEL COMPOUND, AGENT AND NK3 RECEPTOR ANTAGONIST

PROBLEM TO BE SOLVED: To provide a NK3 receptor antagonist that inhibits the propagation of animals without adverse effect on an ecological system. SOLUTION: The present invention provides a compound represented by formula (I') (R1 is H, a hydroxy group or the like; R2 is a hydroxy group, a mercapto group or the like; R3 is a phenyl group or naphthyl group). SELECTED DRAWING: None COPYRIGHT: (C)2017,JPOandINPIT

QUINOLINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS

The present invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, pharmaceutical compositions comprising them and their use in treating diseases mediated by neurokinin-2 and/or neurokinin-3 (NK-3) receptors, such as sc